Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 500 participants.
Also called NCT04276155
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 500 participants
- Sponsor
- Centre Hospitalier de PAU
- Registry
-
NCT04276155
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04276155. Randomized; no masking; primary purpose treatment. Start 2021-08-03 (actual); primary completion 2027-06-22 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia
- Acronym
- SCA FA
- Condition
- Atrial Fibrillation, Myocardial Infarction
- Intervention (Drug)
- non-systematic prescription of anticoagulant therapy
- Lead sponsor
- Centre Hospitalier de PAU
Record details
- Record id
cardio:ct-nct04276155- Content hash
9bf9f12c5011fe5c1f0956f370d0dda80257fc53b79a60aaf0694e58174c1668